From: A new framework for evaluating the health impacts of treatment for Gaucher disease type 1
Proportion for estimation sample | Coefficient | Robust standard error | 95% CI | |
---|---|---|---|---|
Health State in Previous Year (vs. Mild) | ||||
Mild + Bone Pain | 0.114 | 1.305*** | 0.241 | 0.833, 1.777 |
Mild + SSC | 0.010 | 0.840* | 0.452 | −0.046, 1.727 |
Moderate | 0.344 | 2.581*** | 0.305 | 1.983, 3.179 |
Moderate + SSC | 0.041 | 1.253*** | 0.381 | 0.506, 2.000 |
Marked | 0.028 | 4.504*** | 0.465 | 3.593, 5.416 |
Marked + SSC | 0.062 | 3.617*** | 0.462 | 2.711, 4.524 |
Severe | 0.003 | 4.213*** | 0.698 | 2.845, 5.581 |
Severe + SSC | 0.007 | 6.072*** | 1.374 | 3.380, 8.765 |
Years on Treatment (vs. One Year) | ||||
Two Years | 0.086 | 0.293 | 0.361 | −0.414, 000 |
Three or More Years | 0.807 | 0.315 | 0.305 | −0.283, 0.913 |
Baseline DS3 Category (vs. Mild) | ||||
Moderate | 0.312 | −0.150 | 0.276 | −0.691, 0.391 |
Marked | 0.410 | 0.873*** | 0.274 | 0.336, 1.410 |
Severe | 0.071 | 1.349*** | 0.411 | 0.543, 2.154 |
Not Splenectomized | 0.672 | −1.089*** | 0.250 | −1.578, −0.599 |
Ordered Logistic Cutpoints | ||||
Cutpoint 1 | 0.740 | 0.456 | −0.153, 1.634 | |
Cutpoint 2 | 1.662*** | 0.464 | 0.752, 2.572 | |
Cutpoint 3 | 1.727*** | 0.467 | 0.812, 2.641 | |
Cutpoint 4 | 5.054*** | 0.519 | 4.037, 6.070 | |
Cutpoint 5 | 5.835*** | 0.523 | 4.810, 6.861 | |
Cutpoint 6 | 6.577*** | 0.633 | 5.335, 7.818 | |
Cutpoint 7 | 8.808*** | 0.639 | 7.555, 10.060 | |
Cutpoint 8 | 9.066*** | 0.650 | 7.792, 10.340 | |
Number of Patients | 130 | |||
Number of Observations | 970 |